Inozyme Pharma, Inc. Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Inozyme Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • Inozyme Pharma, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $632K, a 22.1% decline year-over-year.
  • Inozyme Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $4.33M, a 31% increase year-over-year.
  • Inozyme Pharma, Inc. annual Nonoperating Income (Expense) for 2023 was $4.48M, a 177% increase from 2022.
  • Inozyme Pharma, Inc. annual Nonoperating Income (Expense) for 2022 was $1.61M, a 7236% increase from 2021.
  • Inozyme Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was $22K, a 96.4% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.48M +$2.86M +177% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 $1.61M +$1.59M +7236% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $22K -$595K -96.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $617K -$465K -43% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $1.08M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.